Samsung Electronics and TTTech Announce Strategic Partnership to Deliver Next Generation of Autonomous and Safety Technology to Automakers
Samsung Electronics Co. Ltd. today announced a strategic partnership with TTTech, a global leader in the field of robust networking and safety controls. Along with this partnership, Samsung will also make a €75 million strategic investment in TTTech as the first investment from its recently-announced Samsung Automotive Innovation Fund (SAIF), and highlights the company’s commitment to bringing safer cars to the road and ushering in the next generation of mobility. It comes on the heels of Samsung’s $8 billion acquisition of HARMAN, a leader in connected car technology, and marks another significant step for the company in the automotive space.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170913006609/en/
Samsung Electronics and TTTech Announce Strategic Partnership to Deliver Next Generation of Autonomous and Safety Technology to Automakers (Photo: Business Wire)
TTTech has been active in the automotive space for years, providing technology to a variety of manufacturers. Samsung’s future investment complements TTTech’s longstanding partnership with AUDI AG and their combined efforts in highly automated piloted driving systems for Volkswagen Group. TTTech’s safety technologies power the zFAS piloted control platform in the 2017 Audi A8.
Beyond automotive, TTTech has improved the safety and reliability of networked computer systems in the aerospace and industrial sectors, with its technologies found in the Boeing 787 Dreamliner and NASA’s Orion spacecraft.
“Automotive advances like autonomous controls and advanced driver assistance systems will have a profound impact on society—from transforming urban spaces to bringing mobility to aging populations. At Samsung, we see it as our responsibility to invest in the technologies that will revolutionize the way we live, work, and connect with one another,” said Young Sohn, President and Chief Strategy Officer of Samsung Electronics and Chairman of the Board for HARMAN. “TTTech has demonstrated a remarkable ability to innovate and build world-class technologies and platforms. This is a seminal moment for Samsung and our Automotive Innovation Fund, and we look forward to working with leading OEMs like Audi and the entire TTTech team to set a new standard for automotive-safety technology.”
“We’re excited about Samsung’s commitment to TTTech and the joint creation of new architecture for open autonomous and ADAS technologies, involving multiple key automotive players and suppliers,” said Alejandro Vukotich, Vice President Autonomous Driving of AUDI AG.
“We are very proud to have Samsung as an investor and partner in TTTech to create solutions for the next generation of highly integrated and data-intensive safety systems,” said Georg Kopetz, Member of the Board at TTTech. “Samsung brings a breadth and a depth of technologies as well as an ecosystem of partners to accelerate development for level 2 to level 5 autonomous platforms.”
“Together we will build products to support new NCAP requirements, solutions for in-vehicle infotainment systems, and new scalable architectures to support fully autonomous vehicles across various industries,” stated Stefan Poledna, Member of the Board at TTTech.
At a transformative moment for the auto industry, TTTech plans to use Samsung’s investment to accelerate the growth of its safety technology for autonomous driving and operations. The company’s collaborative and flexible technology—like its new open safety platform, MotionWise—enables OEMs and Tier-1 suppliers to accelerate the development, integration, and validation of new capabilities in their vehicles.
Together, Samsung and HARMAN are fostering the development of cutting-edge automotive safety technologies like those from TTTech, which will raise the bar for automotive safety controls and ADAS throughout the industry. HARMAN, a Tier 1 supplier, now makes TTTech’s open safety solutions available to the leading global automotive OEMs.
President Young Sohn will join Ricky Hudi, founder and managing director of Future Mobility Technologies, and other industry experts on TTTech Auto division’s new supervisory board.
About TTTech
TTTech is a global leader in the field of robust networking and safety controls. TTTech solutions improve the safety and reliability of electronic systems in the industrial and transportation sectors, with a portfolio of products that are helping to make the Industrial Internet of Things and autonomous driving a reality.
Thanks to the platform-based architecture, TTTech Auto’s production proven solutions enable simple system integration with shorter time-to-market and significant cost reductions for customers. TTTech solutions support highly scalable and modular open real-time control architectures based on Deterministic Ethernet and operates within a rich ecosystem of technology partners.
More information about TTTech and TTTech Auto is available at www.tttech.com
About Samsung Electronics Co., Ltd.
Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems, and memory, system LSI, foundry and LED solutions. For the latest news, please visit the Samsung Newsroom at http://news.samsung.com.
Forward Looking Statement
This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including but are not limited to, statements regarding the benefits of the strategic partnership between Samsung and TTTech Auto; the development of next-generation solutions for auto safety systems; and the ability of TTTech technology to enable OEMs and other customers to build advance auto safety solutions. These and any other forward-looking statements in this release are based on the parties’ current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, changes in the markets and the regulatory environment of automobile technology industries, difficulties in integrating technologies of the parties in the partnership, the inability of the new solutions to achieve wide market acceptance , and the ability to compete with other products in the market. The companies are providing the information in this release as of this date and do not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170913006609/en/
Contact information
TTTech Computertechnik AG
Marco Lehner
Marketing Communications
pr@tttech.com
or
Samsung
Strategy & Innovation Center
Daniel Yoo
Sr. Manager,
Communications
Dan.yoo@samsung.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom